News

  • AI neurology market to reach US$2.5bn by 2030

    The AI neurology market will grow from US$705.6m in 2025 to US$2.5bn by 2030, driven by rising neurological disorders. The projected growth represents a compound annual growth rate of 28.9 per cent over the five-year period, as healthcare systems increasingly adopt AI tools for diagnosis and treatment of brain conditions. AI technologies are transforming how [...]

  • UK rehab professionals urged to contact MPs ahead of ABI debate

    UK rehab professionals and patient families are being urged to contact their MPs ahead of a Westminster Hall debate on acquired brain injury (ABI), scheduled to take place on Thursday 4 December. The UK Acquired Brain Injury Forum (UKABIF) – which continues to champion greater awareness of brain injury and its long-term impact – says the [...]

  • Hand signals restore stepping in paraplegia

    A non-invasive spinal stimulation system controlled by hand movements enables people with paraplegia to regain stepping control. The technique uses electrical signals from hand muscles to trigger magnetic stimulation of the lumbar spinal cord, allowing patients to initiate and control leg movements. By performing rhythmic hand grips, participants with spinal cord injury were able to [...]

  • Mechanism behind Parkinson’s progression discovered

    Scientists identify how protein droplets trigger the harmful clumping that drives Parkinson's disease, potentially opening new treatment paths. The discovery reveals how ubiquilin-2 protein catalyses the aggregation of alpha-synuclein, the misfolded protein that forms toxic deposits in the brains of people with Parkinson's. These deposits, called Lewy bodies, accumulate in neurons in the substantia nigra [...]

  • Pain doesn’t just challenge your body, it tests your identity, patience and ability to hope

    Our latest patient story we share Natalie’s experience of chronic pain after spinal cord injury following a workplace injury Natalie McCreith (39) from Southport was left with a life-changing spinal cord injury after a half-tonne steel beam fell on her in a workplace accident. Now left with chronic nerve pain, she discusses the impact on [...]

  • eXRt unveils Resynk: VR platform helps therapists meet new stroke rehab guidelines

    Rehabilitation tech company eXRt Intelligent Health has announced the upcoming launch of Resynk, a revolutionary new Platform designed to help stroke therapists deliver faster recovery to those who have suffered a debilitating stroke and meet the challenging new stroke guidelines. With Resynk, therapists can now increase therapy intensity on average 17x more, a key component [...]

  • Untreated sleep apnea raises risk of Parkinson’s, research finds

    People with untreated sleep apnoea face nearly double the risk of Parkinson's; using CPAP therapy appears to cut that risk, the study of 11m veterans suggests. The study of more than 11 million US military veterans found that using continuous positive airway pressure (CPAP) therapy significantly reduced this heightened risk. Obstructive sleep apnoea (OSA) is [...]

  • Red Bull driver auctions GP helmet for spinal charity

    Formula 1 driver Yuki Tsunoda will hold a helmet auction to raise funds for spinal cord injury research after racing in Las Vegas. All proceeds from the sale of the specially designed helmet will go to the Wings for Life Spinal Cord Research Foundation, which funds research into treatments and potential cures for spinal cord [...]

  • A stylish new vehicle for Natalie

    The UK’s Wheelchair Accessible Vehicle specialists Brotherwood were delighted to deliver a stylish new vehicle for Natalie – a stunning Hyacinth Red Mercedes-Benz V-Class with the incredible ‘Klastar’ WAV conversion. The luxurious new adapted vehicle enables Natalie to travel inclusively with her family, with exceptional ride comfort – perfect for everything from day to day [...]

  • Bayer stroke drug sees positive results in clinical trials

    Asundexian reduced recurrent stroke without extra major bleeding in a phase III trial of over 12,300 patients on standard antiplatelets, according to topline results from Bayer. The once-daily oral medicine lowered the risk of repeat strokes in people who had a non-cardioembolic ischaemic stroke or a high-risk transient ischaemic attack (TIA). Non-cardioembolic strokes are not [...]